Evidence map›Paper›PMID 40986369›Full record

ArticleMicrobiology (Reading, England)2025

Factors affecting CRISPR-Cas defense against antibiotic resistance plasmids harboured by

Tahira Amdid Ratna, Belle Marco Sharon, Cesar Alejandro Barros Velin, Kelli Palmer

Abstract read
In one paragraph

Article in Microbiology (Reading, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Microorganisms · 2026
    Review
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Tahira Amdid RatnaDepartment of Biological Sciences, The University of Texas at Dallas, Richardson, 75080, Texas, USA.
Belle Marco SharonDepartment of Biological Sciences, The University of Texas at Dallas, Richardson, 75080, Texas, USA.
Cesar Alejandro Barros VelinDepartment of Biological Sciences, The University of Texas at Dallas, Richardson, 75080, Texas, USA.
Kelli PalmerDepartment of Biological Sciences, The University of Texas at Dallas, Richardson, 75080, Texas, USA.

Funding

Genome defense and acquired antibiotic resistance in Enterococcus faecalis and Enterococcus faeciumR01AI116610 · NIAID · UNIVERSITY OF TEXAS DALLAS · PI PALMER, KELLI LEA · 2015 to 2019
$1.9M
NIAID NIH HHS R01 AI116610
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CRISPR-Cas SystemsDrug Resistance, Multiple, BacterialEnterococcus faecalisPlasmidsAnti-Bacterial AgentsConjugation, GeneticGene Transfer, HorizontalGram-Positive Bacterial InfectionsHumansAnti-Bacterial Agentsantibiotic resistanceCRISPR-CasEnterococcus faecalishorizontal gene transfermobile genetic elementplasmid

Identifiers

PMID40986369
PMCPMC12476151

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.